Abstract
Background: Dysphagia of various origins is widespread. There is a high risk of developing formidable complications: malnutrition, dehydration, weight loss, airway obstruction, aspiration pneumonia. The product Softia S is used to solve the problems of swallowing liquids. The Ministry of Agriculture, Forestry and Fisheries of Japan financed this study within the framework of the 8-Point Cooperation Plan presented by the Prime Minister of Japan S. Abe to the President of the Russian Federation V. V. Putin in May 2016. Aims: Assessment of the efficacy and safety of NUTRIs Softia S product for patients with dysphagia of various origins. Materials and methods: Complex assessment of dysphagia included speech therapy, video fluoroscopy and video laryngoscopy with assessment of swallowing function Rosenbek (PAS) and FEDSS scales. Patients were divided into 2 groups (experiment and control). The study lasted 14 days. Examination by a speech therapist and a nutritionist was carried out daily. On the 1st and 14th days, laboratory parameters were monitored, and the patients body weight was determined. Results: The study included 30 patients with mild dysphagia. By the end of the study, 8 people in the experimental group showed a restoration of the swallowing function, residual effects in the form of choking persisted in 7 people. In the control group, a slight improvement was observed in 2 patients, 13 had no changes. The most significant changes were found in the experimental group for the indicators "Time of eating" ("Breakfast", on average, 3.7 minutes, p=0.0033; "Lunch", on average, 6.9 minutes, p 0.0001); "The number of chokes after hydration" ("Breakfast" by an average of 7.0, p 0.0001; "Lunch" by an average of 8.1, p 0.0001; "Dinner" by an average of 6.8, p 0.0001); "The number of chokes during hydration" ("Breakfast" by an average of 8.8, p 0.0001; "Lunch" by an average of 12.1, p 0.0001; "Dinner" by an average of 8.7, p 0.0001). The number of dysphonia cases with sputum significantly decreased only in the experimental group. Conclusions: Softia S can be used in complex therapy for dysphagia by reducing the amount of choking after and during hydration and time of eating and dysphonia cases with sputum.
Highlights
There is a high risk of developing formidable complications: malnutrition, dehydration, weight loss, airway obstruction, aspiration pneumonia
Softia S can be used in complex therapy for dysphagia by reducing the amount of choking after and during hydration and time of eating and dysphonia cases with sputum
Наиболее значимые изменения обнаружены для показателей «Время приема пищи, эксперимент» (в среднем на 3,7 мин; p=0,0033); «Количество поперхиваний после гидратации, эксперимент» (в среднем на 7,0 мин; p
Summary
Эффективность применения продукта Софтиа Эс компании NUTRI у пациентов с дисфагией. Цель — оценка эффективности и безопасности применения загустителя Софтиа Эс компании NUTRI для пациентов с дисфагией различного генеза. В контрольной группе незначительное улучшение наблюдалось у 2 пациентов, в 13 случаях не отмечено изменений в степени дисфагии. В экспериментальной группе также значимо, в отличии от контрольной группы, снизилось число случаев дисфонии с мокротой. Можно сделать вывод о целесообразности применения Софтиа Эс в составе комплексной терапии дисфагии для облегчения приема пищи у пациентов за счет снижения количества поперхиваний после и во время гидратации, а также времени приема пищи и случаев дисфонии с мокротой. Для цитирования: Пряникова Н.И., Быкадорова А.А., Поликарпова О.С., Щелкунова И.Г., Петрова М.В. Эффективность применения продукта Софтиа Эс компании NUTRI у пациентов с дисфагией // Клиническое питание и метаболизм.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
